Delivery Order SPE2DB25D7068-SPE2DB25FTWKA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count units) with a ceiling value of $1,673.10. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by June 5, 2025. The product will be performed and delivered from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count bottles) with a contract ceiling value of $1,801.61. This firm fixed-price delivery order, which is set to conclude on September 30, 2025, represents a non-set-aside competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count units) with a ceiling value of $1,190.65. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count bottles) with a ceiling value of $1,028.46. This competitively awarded, firm fixed-price delivery order is scheduled for completion by April 25, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was open to all...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count units) with a ceiling value of $2,478.27. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of September 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and fulfills the order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count) with a ceiling value of $1,051.66. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by June 2, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,276.11 to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count bottles). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count units) on May 12, 2025, with a ceiling value of $1,533.59 and an ultimate completion date of May 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count packaging) with a ceiling value of $1,312.22. This non-set-aside, competitively awarded contract employs firm fixed pricing and is scheduled for ultimate completion by October 30, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count) at a ceiling value of $1,654.95. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract utilizes an Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTWKADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count) with a ceiling value of $1,291.52. This contract represents a firm fixed-price delivery order with an ultimate completion date of April 25, 2025. The award was made without set-aside designation, indicating it was awarded through open competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems, with demonstrated capability to fulfill federal medical procurement requirements across multiple therapeutic domains through competitive awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/24/25 |